Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Other Non-Current Liabilities (2016 - 2026)

Amphastar Pharmaceuticals has reported Other Non-Current Liabilities over the past 12 years, most recently at $30.0 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 330.92% year-over-year to $30.0 million; the TTM value through Dec 2025 reached $30.0 million, up 330.92%, while the annual FY2025 figure was $30.0 million, 330.92% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $30.0 million at Amphastar Pharmaceuticals, up from $7.0 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $30.0 million in Q4 2025 and troughed at $6.1 million in Q4 2023.
  • A 5-year average of $15.3 million and a median of $15.0 million in 2021 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: surged 334.57% in 2021 and later crashed 74.27% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $15.7 million in 2021, then plummeted by 53.84% to $7.2 million in 2022, then fell by 16.04% to $6.1 million in 2023, then grew by 14.69% to $7.0 million in 2024, then surged by 330.92% to $30.0 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for AMPH at $30.0 million in Q4 2025, $7.0 million in Q3 2025, and $27.8 million in Q2 2025.